During the past decade, IPS Research Company conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 71 clinical trials were completed, i.e. on average, 85.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 49 clinical trials were completed. i.e. 257.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IPS Research Company" #1 sponsor was "Shire" with 21 trials, followed by "Forest Laboratories" with 9 trials sponsored, "Sunovion" with 9 trials sponsored, "Pfizer" with 8 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 8 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IPS Research Company" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "IPS Research Company" are "Major Depressive Disorder" (21 trials), "Depressive Disorder, Major" (12 trials), "ADHD" (9 trials), "Attention Deficit Hyperactivity Disorder" (8 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (7 trials). Many other conditions were trialed in "IPS Research Company" in a lesser frequency.

Most popular intervention types in "IPS Research Company" are "Drug" (132 trials), "Other" (12 trials), "Biological" (5 trials), "Device" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (65 trials), "Dasotraline" (6 trials), "Rapastinel" (5 trials), "placebo" (4 trials) and "Fluoxetine" (3 trials). Other intervention names were less common.

The vast majority of trials in "IPS Research Company" are 136 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "IPS Research Company". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 109 completed trials in IPS Research Company, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in IPS Research Company, 3 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 4 trials that are defined as “Not Applicable".